Clinical Trials on Lupus Nephritis - WHO Class IV
Total 304 results
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIGermany
-
Artiva Biotherapeutics, Inc.RecruitingLupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIUnited States
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - World Health Organization (WHO) Class III | Lupus Nephritis - WHO Class IVUnited States
-
Ohio State UniversityMallinckrodtWithdrawnSLE Glomerulonephritis Syndrome, WHO Class VUnited States
-
Imperial College LondonKarolinska Institutet; Ohio State University; Dutch Working Party on Systemic... and other collaboratorsTerminatedSystemic Lupus Erythematosus, Lupus NephritisUnited Kingdom
-
University Hospital, GrenobleInstitut de Biologie Structurale GrenobleCompletedSystemic Lupus Erythematosus NephritisFrance
-
Sun Yat-sen UniversityCompleted
-
Peking UniversityCompleted
-
Peking Union Medical College HospitalUnknownNephritis, LupusChina
-
Assiut UniversityUnknownActivity of Lupus Nepheritis
-
Hager ZanatyNot yet recruitingGut Microbiota Dysbiosis in Lupus Nepheritis
-
Seoul National University HospitalSeoul National University Bundang Hospital; Chung-Ang University Hosptial,... and other collaboratorsRecruitingLupus Nephritis | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Glomerular Disease | Minimal Change Disease | Membranous Nephropathy | Crescentic GlomerulonephritisKorea, Republic of
-
Minia UniversityNot yet recruitingmfERG in Lupus NephritisEgypt
-
Centre Hospitalier Universitaire, AmiensCompletedLupus Nephritis | Systemic Lupus Erythematosus (SLE)France
-
La Jolla Pharmaceutical CompanyCompletedAutoimmune Diseases | Systemic Lupus Erythematosus | Lupus Nephritis | Immunologic Diseases | Lupus GlomerulonephritisUnited States, Austria, Canada, France, Germany, Italy, Mexico, Spain, Sweden, United Kingdom
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingAutoimmune Diseases | Lupus Nephritis | Immune NephritisChina
-
Assiut UniversityUnknown
-
Istituto Giannina GasliniWithdrawnSystemic Lupus Erythematosus NephritisItaly
-
RenJi HospitalNot yet recruitingWhether Belimumab Could Reduce 2-year Risk of New-onset Lupus Nephritis
-
Universidad de los Andes, ChileRecruitingLupus Erythematosus, Systemic | Lupus GlomerulonephritisChile
-
Fundacin Biomedica Galicia SurGermans Trias i Pujol Hospital; Hospital del Mar; Hospital Universitario 12 de... and other collaboratorsRecruitingSystemic Lupus Erythematosus | Lupus NephritisSpain
-
RenJi HospitalThe First Affiliated Hospital with Nanjing Medical University; Changhai Hospital and other collaboratorsUnknown
-
Assistance Publique Hopitaux De MarseilleActive, not recruiting
-
Liga Panamericana de Asociaciones de Reumatologia...Janssen Research & Development, LLCRecruiting
-
Genentech, Inc.Roche Pharma AGTerminatedSystemic Lupus Erythematosus | Lupus Nephritis
-
Istituto Giannina GasliniUnknown
-
University Hospital, GenevaEuropean Society for Blood and Marrow TransplantationRecruitingChildren Who Receive a Stem Cell Transplantation With Busulfan IVCanada, France, Switzerland
-
Chitwan Medical CollegeCompletedTo Compare the Effects of Mycophenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis Patients
-
Wuerzburg University HospitalCharite University, Berlin, Germany; Goethe University; RWTH Aachen University; Technical University of Munich and other collaboratorsRecruitingSurgery | ASA Class III/IV Patients | Clinical Decision Support SystemsGermany
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHeart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IVUnited States
-
Comunicare Solutions SAKU Leuven; Jessa Hospital; Cliniques universitaires Saint-Luc- Université Catholique... and other collaboratorsRecruitingHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IVBelgium
-
Elpen Pharmaceutical Co. Inc.WithdrawnHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV
-
Tanta UniversityUnknownProliferative Nephritis | Chloroquine RetinopathyEgypt
-
TakedaNot yet recruitingRefractory Lupus NephritisUnited States
-
Aurinia Pharmaceuticals Inc.Labcorp Corporation of America Holdings, IncNot yet recruitingAdolescent Lupus NephritisUnited States
-
Aurinia Pharmaceuticals Inc.Labcorp Drug Development IncRecruiting
-
Vera Therapeutics, Inc.SuspendedLupus Nephritis (LN)United States, Puerto Rico, Spain
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingSystemic Lupus Erythematosus | Lupus NephritisChina
-
Cliniques universitaires Saint-Luc- Université...RecruitingLupus NephritisBelgium
-
Baxalta now part of ShireTerminatedSystemic Lupus ErythematosusAustralia, United States, New Zealand, Mexico, Canada
-
Institute of Rheumatology, PragueCharles University, Czech Republic; Palacky University; Ministry of Health, Czech... and other collaboratorsCompletedSystemic Lupus Erythematosus | Lupus NephritisCzech Republic
-
University of Auckland, New ZealandCounties Manukau Health; Auckland Medical Research Foundation; Auckland District... and other collaboratorsUnknown
-
Universitaire Ziekenhuizen KU LeuvenCompletedPatients With Any Condition Who Need a PICC for IV TherapyBelgium
-
Chang Gung Memorial HospitalRecruitingSystemic Lupus Erythematosus | Ketogenic DietingTaiwan
-
Beijing Tiantan HospitalZhongSheng BioTech Inc.RecruitingWHO Grade III Gliomas | WHO Grade IV GliomasChina
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AGRecruitingLupus Nephritis | Systemic Lupus Erythematosus (SLE)France
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedA Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus NephritisLupus NephritisUnited States, Canada, France, Russian Federation, United Kingdom
-
GlaxoSmithKlineRecruitingSystemic Lupus ErythematosusUnited Arab Emirates
-
University of GöttingenKing's College London; Università degli Studi di BresciaRecruiting
-
Sohag UniversityUnknownWe Aim to Examine the Predictors of Sustained Complete Renal Remission in Patients With Lupus Nephritis at Sohag University HospitalEgypt